Genomic Health Inc (GHDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,757 | 8,249 | 7,846 | 4,288 | -9,411 |
| Depreciation Amortization | 6,324 | 5,471 | 7,310 | 7,180 | 6,591 |
| Accounts receivable | -7,193 | -1,176 | -6,771 | -3,183 | -2,316 |
| Accounts payable and accrued liabilities | 1,238 | -2,144 | 3,057 | 2,664 | -594 |
| Other Working Capital | -4,008 | -3,046 | -4,578 | -199 | -2,545 |
| Other Operating Activity | 24,948 | 18,608 | 15,737 | 10,833 | 13,101 |
| Operating Cash Flow | $8,552 | $25,962 | $22,601 | $21,583 | $4,826 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,986 | -13,410 | -21,990 | 2,702 | -3,093 |
| PPE Investments | -10,992 | -9,850 | -6,183 | -4,442 | -3,744 |
| Purchase Of Investment | -5,000 | -4,963 | -2,300 | -500 | 0 |
| Investing Cash Flow | $-7,006 | $-28,223 | $-30,473 | $-2,240 | $-6,837 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 16,588 | 18,764 | 9,558 | 2,983 | 1,736 |
| Common Stock Repurchased | -15 | -30,095 | N/A | N/A | N/A |
| Other Financing Activity | -2,845 | -1,272 | 0 | -225 | -1,814 |
| Financing Cash Flow | $13,728 | $-12,603 | $9,558 | $2,758 | $-78 |
| Beginning Cash Position | 18,005 | 32,869 | 31,183 | 9,082 | 11,171 |
| End Cash Position | 33,279 | 18,005 | 32,869 | 31,183 | 9,082 |
| Net Cash Flow | $15,274 | $-14,864 | $1,686 | $22,101 | $-2,089 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,552 | 25,962 | 22,601 | 21,583 | 4,826 |
| Capital Expenditure | -11,008 | -10,056 | -6,183 | -4,442 | -3,744 |
| Free Cash Flow | -2,456 | 15,906 | 16,418 | 17,141 | 1,082 |